IFP Advisors’s Array Biopharma Inc ARRY Stock Holding History

IFP Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,831	Closed	-$40K	–	3845
2018 Q4	$40K	Buy	+2,831	New	+$42.9K	﹤0.01%	1739

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

IFP Advisors's ARRY Position: Q1 2019 in Review

IFP Advisors sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 2,831 shares — an estimated $40K sold.

IFP Advisors first reported a position in ARRY in Q4 2018 and held it in 1 quarter. The position peaked at $40K in Q4 2018. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

IFP Advisors reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
IFP Advisors sold 2,831 Array Biopharma Inc shares in Q1 2019, an estimated $40K.
IFP Advisors first reported a position in Array Biopharma Inc in Q4 2018 and held it in 1 quarter.
IFP Advisors's Array Biopharma Inc position peaked at $40K in Q4 2018.
268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.